Akorn Overview

  • Year Founded
  • 1971

Year Founded

  • Status
  • Out of Business

  • Employees
  • 2,000

Employees

  • Latest Deal Type
  • Liquidation

  • Financing Rounds
  • 8

  • Investments
  • 13

Akorn General Information

Description

Akorn Inc is a pharmaceutical company. It is engaged in the development, manufacturing, and marketing of generic and prescription pharmaceuticals. The firm has two segments namely Prescription Pharmaceuticals and Consumer Health. The Prescription Pharmaceuticals segment consists of generic and branded prescription pharmaceuticals including sterile ophthalmics, injectables, and inhalants, and non-sterile oral liquids, topicals and nasal sprays whereas the Consumer Health segment consist of animal health and over-the-counter products, both branded and private-label. The company generates a majority of its revenue from the Prescription Pharmaceuticals segment.

Contact Information

Website
www.akorn.com
Formerly Known As
Akorn Ophthalmics
Ownership Status
Out of Business
Financing Status
Corporation
Corporate Office
  • 5605 CenterPoint Court
  • Gurnee, IL 60031
  • United States
+1 (800)
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Distributors (Healthcare)
Vertical(s)
Manufacturing
Former Stock Listing
FDA
Corporate Office
  • 5605 CenterPoint Court
  • Gurnee, IL 60031
  • United States
+1 (800)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Akorn Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Akorn‘s full profile, request access.

Request a free trial

Akorn Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Akorn Inc is a pharmaceutical company. It is engaged in the development, manufacturing, and marketing of generic and pre
Pharmaceuticals
Gurnee, IL
2,000 As of 2018

Haifa Bay, Israel
 

Bridgewater, NJ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Akorn Competitors (26)

One of Akorn’s 26 competitors is Taro Pharmaceutical Industries, a Corporate Backed or Acquired company based in Haifa Bay, Israel.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Taro Pharmaceutical Industries Corporate Backed or Acquired Haifa Bay, Israel
Amneal Pharmaceuticals Formerly PE-Backed Bridgewater, NJ
Eisai (Germany) Corporation Frankfurt, Germany
ANI Pharmaceuticals Corporation Baudette, MN
Acerus Pharmaceuticals Corporation Mississauga, Canada
You’re viewing 5 of 26 competitors. Get the full list »

Akorn Patents

  • 27

    Total Documents Applications and Grants

  • Total Patents Families

  • 1

    Granted

  • Pending

  • Expiring in next 12 mo

Akorn Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10426834-B1 Methods of sterilizing drugs Inactive 11-Aug-2016
US-9517269-B1 Stable pentobarbital formulation Inactive 01-Oct-2013
US-20120034307-A1 Aqueous gel formulation and method for inducing topical anesthesia Inactive 24-Jul-2006
US-20080020044-A1 Aqueous gel formulation and method for inducing topical anesthesia Inactive 24-Jul-2006
EP-2043601-A1 Aqueous gel formulation and method for inducing topical anesthesia Inactive 24-Jul-2006 A61K9/0048
To view Akorn’s complete patent history, request access »

Akorn Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Akorn Investments & Acquisitions (13)

Akorn’s most recent deal was a Merger/Acquisition with Akorn (Therapeutic Devices) for . The deal was made on 02-Jan-2015.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Akorn (Therapeutic Devices) 02-Jan-2015 Merger/Acquisition Therapeutic Devices
Xopenex 30-Sep-2014 Merger/Acquisition Pharmaceuticals
VersaPharm 12-Aug-2014 Merger/Acquisition Pharmaceuticals
Hi-Tech Pharmacal 17-Apr-2014 Merger/Acquisition Pharmaceuticals
BETIMOL 02-Jan-2014 Corporate Asset Purchase Buildings and Property
You’re viewing 5 of 13 investments and acquisitions. Get the full list »

Akorn Exits (3)

Akorn’s most recent exit was on 02-Jan-2015 from Akorn (Therapeutic Devices). The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Akorn (Therapeutic Devices) 02-Jan-2015 Completed
Nicox Ophthalmics 11-Aug-2011 Completed
  • 5 buyers
TheraTears 03-May-2011 Merger/Acquisition Completed
To view Akorn’s complete exits history, request access »

Akorn FAQs

  • When was Akorn founded?

    Akorn was founded in 1971.

  • Where is Akorn headquartered?

    Akorn is headquartered in Gurnee, IL.

  • What is the size of Akorn?

    Akorn has 2,000 total employees.

  • What industry is Akorn in?

    Akorn’s primary industry is Pharmaceuticals.

  • Is Akorn a private or public company?

    Akorn is a Private company.

  • What is Akorn’s current revenue?

    The current revenue for Akorn is .

  • Who are Akorn’s competitors?

    Taro Pharmaceutical Industries, Amneal Pharmaceuticals, Eisai (Germany), ANI Pharmaceuticals, and Acerus Pharmaceuticals are some of the 26 competitors of Akorn.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »